Skip to main content
SpringerLink
Log in

Healthcare Governance and Climate Change Adaptation: A Pharmaceutical Industry Perspective

  • Chapter
  • First Online:
Millennium Development Goals and Community Initiatives in the Asia Pacific

  • 1080 Accesses

Abstract

The 4th assessment report of the Intergovernmental Panel on Climate Change (IPCC) concludes that ‘the global burden of disease and premature deaths’ are somewhat contributed by climate change (IPCC, Introduction to the working group II – fourth assessment report. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE (eds) Climate change 2007: impacts, adaptation and vulnerability. Cambridge University Press, Cambridge, pp 1–6, 2007). The extant literature and scientific evidence on climate change and public health also suggest that climate change could create one of the biggest challenges to public health and its future governance. This does not only have profound impact on public sector health services but also poses significant threats to private sector health service providers. One of the private sector establishments that tend to become directly affected by climate change is the pharmaceutical industry. Given the scenario of uncertainty and risk associated with climate change, this industry appears to be in a unique albeit intricate situation as it faces both risks and opportunities as a consequence of climate change. As climate change adaptation entails both risk aversion and opportunity utilisation, it may, therefore, be considered useful to study the pharmaceutical industry in relation to its exposure to climate change and subsequent adaptation measures. Given the paramount importance of climate change adaptation by the pharmaceutical industry and its social and environmental implications, the issue of governance becomes an indispensible part of any such study. Following a scrutiny of the extant literature and recent scientific evidence on climate change, this chapter aims to present climate change adaptation strategies adopted by the pharmaceutical industry. The role of government in managing or moderating these strategies is also considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Accenture, GlaxoSmithKline & the Smith School of Enterprise and the Environment (2011) Climate change and health: framing the issue. Accenture, New York

    Google Scholar 

  • ADB (Asian Development Bank) (2011) Accounting for health impacts of climate change. Asian Development Bank, Mandaluyong City

    Google Scholar 

  • Ahmed AU (2006) Bangladesh: climate change impacts and vulnerability: a synthesis. Climate Change Cell, Department of Environment, Dhaka

    Google Scholar 

  • As-Saber SN (2009) Rediscovering the role of governments in the present era of governance. In: As-Saber SN, Singh A, Ahmad R, Jalal J (eds) Strengthening governance in the Asia Pacific: myths, realities and paradoxes. McMillan, New Delhi, pp 1–16

    Google Scholar 

  • Atkins P (1999) Chlorofluorocarbon to hydrofluoroalkane formulations: an industry perspective. J Allergy Clin Immunol 104(6):268–270

    Article  Google Scholar 

  • Babovic S, Wasan KM (2011) Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals. J Pharm Sci 100(3):816–821

    Article  Google Scholar 

  • Berkhout F, Hertin J, Gann DM (2006) Learning to adapt: organizational adaptation to climate change impacts. Clim Chang 78(1):135–156

    Article  Google Scholar 

  • Binns C, Low WY (2011) Climate change: the greatest equity issue in public health. Asia Pac J Public Health 23(2, supplement):5S–6S

    Article  Google Scholar 

  • Chaudhuri S, Goldberg PK, Jia P (2006) Estimating the effects of global patent protection in pharmaceuticals: a case study of quinolones in India. Am Econ Rev 96(5):1477–1514

    Article  Google Scholar 

  • Cogan D, Good M, Kantor G, McAteer E (2008) Corporate governance and climate change: consumer and technology companies. Ceres, Inc., Boston

    Google Scholar 

  • Confalonieri U, Menne B, Akhtar R, Ebi KL, Hauengue M, Kovats RS, Revich B, Woodward A (2007) Human health. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE (eds) Climate change 2007: impacts, adaptation and vulnerability. Cambridge University Press, Cambridge, pp 391–431

    Google Scholar 

  • Connor SJ, Omumbo J, Green C, DaSilva J, Mantilla G, Delacollette C, Hales S, Rogers D, Thomson M (2010) Health and climate: needs. Procedia Environ Sci 1:27–36

    Article  Google Scholar 

  • Costello A, Abbas M, Allen A, Ball S, Bell S, Bellamy R, Friel S, Groce N, Johnson A, Kett M, Lee M, Levy C, Maslin M, McCoy D, McGuire B, Montgomery H, Napier D, Pagel C, Patel J, Antonio J, de Oliveira P, Redclift N, Rees H, Rogger D, Scott J, Stephenson J, Twigg J, Wolff J, Patterson C (2009) Managing the health effects of climate change. Lancet 373:1693–1733

    Article  Google Scholar 

  • Epstein PR (2005) Climate change and human health. N Engl J Med 353(14):1433–1436

    Article  Google Scholar 

  • Fidler DP (2010) The challenges of global health governance. Council on Foreign Relations, New York

    Google Scholar 

  • Gardiner D, Anderson M, Schlesinger R, Gorte JF, Zeller D (2007) Climate risk disclosure by the S&P 500. Ceres, Inc., Boston

    Google Scholar 

  • Greve J (2008) Healthcare in developing countries and the role of business: a global governance framework to enhance the accountability of pharmaceutical companies. Corp Gov 8(4):490–505

    Article  Google Scholar 

  • Grover A, Citro B (2011) India: access to affordable drugs and the right to health. Lancet 377(9770):976–977

    Article  Google Scholar 

  • Hanna EG, Kjellstrom T, Bennett C, Dear K (2011a) Climate change and rising heat: population health implications for working people in Australia. Asia Pac J Public Health 23(2, supplement):14S–26S

    Article  Google Scholar 

  • Hanna EG, Spickett JT, Spickett JT (2011b) Climate change and human health: building Australia’s adaptation capacity. Asia Pac J Public Health 23(2, supplement):7S–13S

    Article  Google Scholar 

  • Husain T, Chaudhary JR (2008) Human health risk assessment due to global warming: a case study of the Gulf countries. Int J Environ Res Public Health 5:204–212

    Article  Google Scholar 

  • IIED (International Institute for Environment and Development) & Irish Aid (2011) Health: mainstreaming environment and climate change. IIED, London

    Google Scholar 

  • IPCC (Intergovernmental panel on Climate Change) (2007) Introduction to the working group II – fourth assessment report. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE (eds) Climate change 2007: impacts, adaptation and vulnerability. Cambridge University Press, Cambridge, pp 1–6

    Google Scholar 

  • Kaufmann D, Kraay A, Mastruzzi M (2009) Governance matters VIII: aggregate and individual governance indicators 1996–2008. World Bank Publication, Washington, DC

    Google Scholar 

  • King MD, Sarria P, Moss DJ, Numark NJ (2004) U.S. Business actions to address climate change: case studies of five industry sector. Green Business Network, Washington, DC

    Google Scholar 

  • Kolk A, Pinkse J (2004) Market strategies for climate change. Eur Manag J 22(3):304–314

    Article  Google Scholar 

  • Kolk A, Pinkse J (2005) Business responses to climate change: identifying emergent strategies. Calif Manage Rev 47(3):6–20

    Article  Google Scholar 

  • Kolk A, Pinkse J (2008) A perspective on multinational enterprises and climate change: learning from “an inconvenient truth”? J Int Bus Stud 39(8):1359–1378

    Article  Google Scholar 

  • KPMG International (2008) Climate changes your business: KPMG’s review of the business risks and economic impacts at sector level. Reijnen Offset, Amsterdam

    Google Scholar 

  • Leary NA (1999) A framework for benefit-cost analysis of adaptation to climate change and climate variability. Mitig Adapt Strat Glob Chang 4(3–4):307–318

    Article  Google Scholar 

  • Linnenluecke M, Griffiths A (2010) Beyond adaptation: resilience for business in light of climate change and weather extremes. Bus Soc 49(3):477–511

    Article  Google Scholar 

  • Llewellyn J (2007) The business of climate change: challenges and opportunities. Lehman Brothers, New York

    Google Scholar 

  • Lovell SA (2011) Health governance and the impact of climate change on Pacific small Island developing states. Int Hum Dimen Program (IHDP) Update 1:50–55

    Google Scholar 

  • Malhotra P (2008) The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India. Indian J Med Ethics 5(2):61–65

    Google Scholar 

  • Marques A, Nunes ML, Moore SK, Strom MS (2010) Climate change and seafood safety: human health implications. Food Res Int 43:1766–1779

    Article  Google Scholar 

  • McMichael AJ, Neira M, Bertollini R, Campbell-Lendrum D, Hales S (2009) Climate change: A time of need and opportunity for the health sector. Lancet 374:2123–2125

    Article  Google Scholar 

  • Mitchell SM, Shortell SM (2000) The governance and management of effective community health partnerships: a typology for research, policy, and practice. Milbank Q 78(2):241–289

    Article  Google Scholar 

  • Pang T, Daulaire N, Keusch G, Leke R, Piot P, Reddy S, Rys A, Szlezak N (2010) The new age of global health governance holds promise. Nat Med 16(11):1181

    Article  Google Scholar 

  • Patz JA, Epstein PR, Burke TA, Balbus JM (1996) Global climate change and emerging infectious diseases. J Am Med Assoc 275(3):217–223

    Article  Google Scholar 

  • Porter ME, Reinhardt FL (2007) A strategic approach to climate. Harv Bus Rev 85(10):22–26

    Google Scholar 

  • Ruggie JG (2004) Reconstituting the global public domain: issues, actors, and practices. Eur J Int Relations 10(4):499–531

    Article  Google Scholar 

  • Salt JE (2003) Health climate change: implications for the pharmaceutical sector. Annu Rep Med Chem 38:375–382

    Article  Google Scholar 

  • Satyanarayana K, Srivastava S (2007) Poverty, health & intellectual property rights with special reference to India. Indian J Med Res 126(4):390–406

    Google Scholar 

  • Shukla N, Sangal T (2009) Generic drug industry in India: the counterfeit spin. J Intellect Property Rights 14(3):236–240

    Google Scholar 

  • Siddiqi S, Masud TI, Nishtar S, Sabri B (2006) Framework for assessing health governance in developing countries: gateway to good governance. Presentation made at Health System Metrics Technical Meeting, 28–29 Sept 2006, Montreux-Glion, Switzerland

    Google Scholar 

  • Smit B, Burton I, Klein RJT, Wandel J (2000) An anatomy of adaptation to climate change and variability. Climate Change 45(1):223–251

    Article  Google Scholar 

  • Sturchio JL (2008) Business engagement in public programs: the pharmaceutical industry’s contribution to public health and the millennium development goals. Corp Gov 8(4):482–489

    Article  Google Scholar 

  • UNDP (United Nations Development Program) (2007) Fighting climate change: human solidarity in a divided world. Human Development Report 2007/2008. United Nations Publication, New York

    Google Scholar 

  • Wachira C, Ruger JP (2011) National poverty reduction strategies and HIV/AIDS governance in Malawi: a preliminary study of shared health governance. Soc Sci Med 72(12):1956–1964

    Article  Google Scholar 

  • World Bank (2011) Healthy partnerships: how governments can engage the private sector to improve health in Africa. World Bank, Washington, DC

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Management, RMIT University, Melbourne, Australia

    Md Khalid Hossain & Sharif N. As-Saber

Authors
  1. Md Khalid Hossain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharif N. As-Saber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Md Khalid Hossain .

Editor information

Editors and Affiliations

  1. , Law and Governance, Jawaharlal Nehru University, Nelson Mandela Marg, Delhi, India

    Amita Singh

  2. , Asian Center, University of the Philippines, Diliman, Quezon City, Philippines

    Eduardo T. Gonzalez

  3. , Department of Business and Management St, St. George’s University, University Centre, St. George, Grenada

    Stanley Bruce Thomson

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer India

About this chapter

Cite this chapter

Hossain, M.K., As-Saber, S.N. (2013). Healthcare Governance and Climate Change Adaptation: A Pharmaceutical Industry Perspective. In: Singh, A., Gonzalez, E., Thomson, S. (eds) Millennium Development Goals and Community Initiatives in the Asia Pacific. Springer, India. https://doi.org/10.1007/978-81-322-0760-3_4

Download citation

Publish with us

Policies and ethics

Search

Navigation